riate use of antibiotics have led to an increased rates of bacterial pulmonary infection.[ 3 ] Some studies have shown that consistent use of antiviral/antifungal prophylaxis reduces the incidence of cytomegalovirus and pneumocystis infections.[ 4 ] However, there are other studies which have shown an increasing trend of fungal infection in renal allograft recipients, which is a major cause of posttransplant mortality.[ 5 ] In many instances, the bacterial pathogen remains unidentified.
1
—
—